AbbVie Inc. has declared a quarterly cash dividend of $1.73 per share, with payments scheduled for May 15, 2026, to shareholders of record as of April 15, 2026. The declaration underscores the pharmaceutical company's continued commitment to returning capital to investors through regular dividend distributions.
The dividend announcement reflects AbbVie's track record of consistent shareholder returns since the company's 2013 inception as an independent entity. The pharmaceutical giant has achieved a cumulative dividend increase exceeding 330% over this period, demonstrating sustained earnings growth and financial discipline in capital allocation.
As a member of the [S&P Dividend Aristocrats](/tag/s-p-dividend-aristocrats) Index, AbbVie has qualified for this distinction by meeting rigorous criteria for dividend growth and consistency. The company's dividend policy continues to position it among the equity market's most reliable income-generating equities for institutional and retail investors seeking steady dividend streams.